Comparison of sildenafil and isorbid effects on embery transfer outcome in patients with recurrent implantation failure
Phase 2
Recruiting
- Conditions
- Infertility.Female infertility of tubal originN97.1
- Registration Number
- IRCT20110301005942N8
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
15 to 40 years Patients with a history of double implantation failure who have at least 2 frozen embryos for transfer will be included in the study with consent.
Exclusion Criteria
1.Treatment with hypertension drugs 2.Myoma, adenomyosis, congenital malformations of the uterus, endometriosis 3.History of cardiovascular or renal or liver disease or use of nonsteroidal anti-inflammatory drugs and any chronic disease
Reluctance to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of endometrial thickness. Timepoint: The initial evaluation of endometrial thickness is performed on day 1 to 3 and then 10 days later. Method of measurement: Trans vaginal sonograghy.;BHCG titer examination. Timepoint: Chemical pregnancy 2 weeks after embryo transfer. Method of measurement: Chemical pregnancy with BHCG.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Trans vaginal sonography.